Harmoney Corp Limited (ASX:HMY)
0.6350
+0.0250 (4.10%)
Jul 31, 2025, 4:10 PM AEST
Lumos Pharma Revenue
Harmoney Corp had revenue of 20.93M AUD in the half year ending December 31, 2024, with 19.56% growth. This brings the company's revenue in the last twelve months to 37.09M, up 2.55% year-over-year. In the fiscal year ending June 30, 2024, Harmoney Corp had annual revenue of 35.42M with 2.92% growth.
Revenue (ttm)
37.09M
Revenue Growth
+2.55%
P/S Ratio
1.78
Revenue / Employee
494.57K
Employees
75
Market Cap
66.07M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 35.42M | 1.01M | 2.92% |
Jun 30, 2023 | 34.42M | 5.63M | 19.54% |
Jun 30, 2022 | 28.79M | 14.34M | 99.26% |
Jun 30, 2021 | 14.45M | -1.22M | -7.81% |
Jun 30, 2020 | 15.67M | -13.75M | -46.74% |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Commonwealth Bank of Australia | 26.73B |
National Australia Bank | 20.05B |
Westpac Banking | 21.37B |
ANZ Group Holdings | 21.10B |
Macquarie Group | 17.32B |
QBE Insurance Group | 36.69B |
Computershare | 4.95B |
Suncorp Group | 13.95B |